Opinion on Oncology in Germany

Published within

« | 1 | 2 | » »|

Type Product title / description Pub Price
ResearchWire
ResearchWire

Monoclonal antibodies: sales to increase six-fold by 2005

Published By Datamonitor
19 Apr 2001
ResearchWire
ResearchWire

Cancer: 9% increase in Germany by 2007

Published By Datamonitor
25 Apr 2001
ResearchWire
ResearchWire

Colorectal cancer: sales to top $1 billion by 2007

Published By Datamonitor
08 May 2001
ResearchWire
ResearchWire

Vinka alkaloids: market to fall 17% by 2007

Published By Datamonitor
16 May 2001
ResearchWire
ResearchWire

Cancer: launch of angiogenesis inhibitors will increase treatment options

Published By Datamonitor
25 May 2001
ResearchWire
ResearchWire

Cytotoxic antibiotics: sales down 4% by 2007

Published By Datamonitor
11 Jun 2001
ResearchWire
ResearchWire

Gastric cancer: incidence falling, prevalence rising

Published By Datamonitor
08 Aug 2001
CommentWire
CommentWire

Wilex/4SC: cancer research collaboration should bear fruit

The German biotech companies aim to accelerate the development of products related to Wilex's lead compound WX-293. Both companies should benefit from the deal: Wilex will gain access to the latest targeted drug development technologies, while 4SC will directly increase its revenues through milestone payments.

Published By Datamonitor
14 Jan 2002
ResearchWire
ResearchWire

Prostate cancer: UK lowest for screening

Published By Datamonitor
17 Jan 2002
ResearchWire
ResearchWire

Cancer: French prevalence to rise 2.59% per year

Published By Datamonitor
05 Mar 2002

« | 1 | 2 | » »|

No help is available.